Latest News

There are multiple factors that can affect how patients respond to treatment or how their health is maintained. One that is gaining more attention is how social interactions can benefit a person’s health.
Luminaries from the worlds of research, regulation, and advocacy in diabetes gathered in Bethesda, Maryland, to discuss what future rules for drug and device approvals might look like if things like hypoglycemia and time in range had consideration.
CMS announced it will hold a meeting to gather input on potential models to pay for behavioral healthcare that would improve quality, expand access, and lower costs for beneficiaries.
This Week in Managed Care: July 21, 2017
This week, the top managed care stories included more twists in Senate Republicans' efforts to repeal the Affordable Care Act; a Medicare fraud sweep targeted opioid distribution; and the CDC reported 30 million Americans now have diabetes.
Coverage of our peer-reviewed research in the healthcare and mainstream press.
Social interaction during chemotherapy treatments can positively influence a cancer patient’s health through improving patient outcomes and patient survival rates.
In a webinar hosted by Carevive, researcher Ethan Basch, MD, MSc, discussed the findings of his recent study linking electronic patient-reported outcomes (PROs) to better survival outcomes for patients with cancer.
Michael Griffin Describes Daughters of Charity's Long History of Leadership
In the 180-plus years Daughters of Charity has been in New Orleans, the health system has implemented a number of innovative ideas, from air-conditioned hospitals to community health networks, according to Michael Griffin, president and CEO. The future is looking even brighter as more patients become insured and gain access to care, he added.
The data confirm what Medicaid beneficiaries report and what a study by a Wharton School professor found: physicians' willingness to take on Medicaid patients is directly related to reimbursement rates.
Dr Zirui Song: Working at the Intersection of Clinical Medicine and Health Policy
Zirui Song, MD, PhD, resident at Massachusetts General Hospital, discussed his research interests, which center on strategies to control healthcare spending while improving the quality of care. He also expressed the importance of examining health equity within the United States healthcare system.
The study found that no matter their eating pattern, participants tended to add weight gradually until age 60, then lose it gradually. But those who had most of their calories earlier in the day gained less and lost weight more rapidly after age 60.
Researchers at the University of Pennsylvania have recognized that narrow provider networks are quite likely to exclude National Cancer Institute–Designated Cancer Centers or National Comprehensive Cancer Network Cancer Centers, which could prevent patient access to high-quality cancer care.
In a recently released position statement, the American Society of Clinical Oncology (ASCO) has outlined a pathway that would address the rising costs of cancer drugs in the United States.

From the Journals

A discussion at the 2017 American Society of Clinical Oncology Annual Meeting addressed practical solutions to address the financial toxicity of cancer care and identified leads for future intervention studies aimed to prevent or reduce this burden.
CT-P6, a proposed trastuzumab biosimilar, is safe and effective as a neoadjuvant treatment in HER2–positive early breast cancer, according to research presented at the 2017 American Society of Clinical Oncology Annual Meeting.
Research presented at the 2017 American Society of Clinical Oncology Annual Meeting showed that SB3, a proposed biosimilar to trastuzumab, has comparable efficacy, safety, immunogenicity, and pharmacokinetics to the reference product based on the breast pathological complete response.
After switching studies, research in patients with breast cancer receiving neoadjuvant myelosuppressive chemotherapy has found clinical equivalence between filgrastim and its biosimilar, according to results presented at the 2017 Annual Meeting of the American Society of Clinical Oncology.
The diagnosis of stage I disease increased for female breast cancer, colorectal cancer, and lung cancer following implementation of the Affordable Care Act (ACA), according to research presented at the 2017 American Society of Clinical Oncology Annual Meeting in Chicago.
A poster discussion session at the 2017 Annual Meeting of the American Society of Clinical Oncology led by Katherine Van Loon, MD, MPH, examined retrospective surveillance data in 3 cancers: non–small cell lung cancer, head and neck cancer, and colorectal cancer.
At the 2017 American Society of Clinical Oncology Annual Meeting, oncologists heard from fellow experts on the best way to navigate the daunting challenge of payment reform.
Coverage from the first of 3 Peer Exchange™ discussions from the Diabetes Stakeholders Summit.
Coverage from the first of 3 Peer Exchange™ discussions from the Diabetes Stakeholders Summit.
Compendia
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Formulary
Upcoming Partner Events
August 16-17, 2017
Philadelphia, PA
October 24-25, 2017
San Francisco, CA

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$